Understanding reasons for non-adherence to active surveillance for low-intermediate risk prostate cancer.

ABSTRACT:

Background

Active surveillance (AS) is recommended by most national medical organizations as the preferred treatment option for men with low-risk prostate cancer (PCa). However, studies report that up to one third of men on AS dropout within 5 years, without evidence of disease progression. Despite high dropout rates, few studies have purposively explored the opinions and experiences of men who discontinued AS. The aim of this study was to gain insight into the reasons why some men on AS for PCa discontinue active treatment without evidence of disease progression.

Methods

Semi-structured interviews were undertaken with 14 men from diverse socio-cultural backgrounds who had been on AS for PCa but dropped out of surveillance to undergo active treatment without signs of disease

SUBMITTER: Beckmann K 

PROVIDER: S-EPMC8261438 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature